Coronavirus | Around 30 Indian attempts at COVID-19 vaccine, says Principal Scientific Adviser

K. VijayRaghavan shared the data during the webinar organised by the Confederation for Indian Industry and the Technology Development Board of the Department of Science and Technology.

May 11, 2020 11:01 pm | Updated May 12, 2020 11:39 am IST - NEW DELHI

K. VijayRaghavan

K. VijayRaghavan

There are nearly 30 “attempts” from India to develop vaccines, K. VijayRaghavan, Principal Scientific Adviser to the Union government, said at an online web conference on Friday.

“There are over a 100 vaccines being developed worldwide and at least 30 attempts in India. These include efforts where India is participating in global attempts and partnerships among Indian academia and industry,” he said during the webinar organised by the Confederation for Indian Industry (CII) and the Technology Development Board of the Department of Science and Technology (DST).

NIV initiative

On Saturday, the Indian Council for Medical Research (ICMR) announced a collaboration with the Hyderabad-based Bharat Biotech International Ltd. to develop a potential vaccine based on a SARS-CoV-2 strain isolated at the ICMR-National Institute of Virology in Pune.

Coronavirus | When will a COVID-19 vaccine be ready?

The Pune-based Serum Institute of India has tied up with Oxford University that is testing a vaccine using a weakened adenovirus (which causes common cold). Early trials have already been conducted, and the Serum Institute has said it is ready to start an initial run of production in June, without waiting for clearer results of the vaccine’s efficacy.

Bharat Biotech is also involved in two other vaccine development projects with different groups.

Test kits

At the webinar, Ashutosh Sharma, Secretary, DST, said a major thrust was to develop antibody tests that would help with a graded exit out of the lockdown .

Key ICMR panel on vaccines dissolved

“Lots of professors and heads of institutes from the IITs [Indian Institutes of Technology] ask me how can we reopen colleges and hostels. Having effective testing kits will be useful in taking decisions such as these,” he said.

On Saturday, the Health Ministry announced the development of an ELISA antibody test kit that would help in district-level sero-surveillance. This is a cruder but cheaper way of checking a sample of the population to determine exposure to the virus.

Top News Today

Sign in to unlock member-only benefits!
  • Access 10 free stories every month
  • Save stories to read later
  • Access to comment on every story
  • Sign-up/manage your newsletter subscriptions with a single click
  • Get notified by email for early access to discounts & offers on our products
Sign in


Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.

We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.